Analysis and validation of traits associated with a single nucleotide polymorphism Gly364Ser in catestatin using humanized chromogranin A mouse models-Reference-Cited by-同舟云学术

Analysis and validation of traits associated with a single nucleotide polymorphism Gly364Ser in catestatin using humanized chromogranin A mouse models

Published:2016-01 Issue:1 Volume:34 Page:68-78
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Mir Saiful A.,Zhang Kuixing,Milic Milos,Gu Yusu,Rieg Timo,Ziegler Michael,Vaingankar Sucheta M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference43 articles.

1. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.;Wain;Nat Genet,2011

2. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk.;Ehret;Nature,2011

3. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians.;Kato;Nat Genet,2011

4. Functional genetic variants of the catecholamine-release-inhibitory peptide catestatin in an Indian population: allele-specific effects on metabolic traits.;Sahu;J Biol Chem,2012

5. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.;Rao;Circulation,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum catestatin level is increased in women with preeclampsia;Journal of Obstetrics and Gynaecology;2021-05-03

2. Chromogranin A pathway: from pathogenic molecule to renal disease;Journal of Hypertension;2020-03

3. Animal Models of Hypertension: A Scientific Statement From the American Heart Association;Hypertension;2019-06

4. Genetic-Driven Druggable Target Identification and Validation;Trends in Genetics;2018-07

5. CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION;Russian Journal of Cardiology;2018-05-09